Tengo una respuesta en anticoncepción – Bibliografía

  1. Petitti DB, Clinical practice. Combination estrogen-progestin oral contraceptives. N Engl J Med 2003;349:1443.
  2. Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2008. 8;(4):CD003989.
  3. WHO. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: WHO; 2009. Disponible en http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html
  4. Coney P, Washenik K, Langley RG, DiGiovanna JJ, Harrison DD. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception. 2001;63(6):297-302.
  5. Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group.Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.
  6. Lancet. 2002 Mar 30;359(9312):1085-92.
  7. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, Olson JE, Couch FJ, Anderson KE, Pankratz VS, Sellers TA. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA. 2000.11;284(14):1791-8.
  8. Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception. 2006;73(6):566-70.
  9. http://www.aemps.es/actividad/alertas/usoHumano/seguridad/home.htm#2001

10. Otero R., Grau E., Jiménez D., Uresandi F., López J.L., Calderón E. et al. Profilaxis de la enfermedad tromboembólica. Arch Bronconeumol 2008;44(3):160-9

11. Schindler AE. Non-contraceptive benefits of hormonal contraceptives. Minerva Ginecol. 2010;62(4):319-29.

12.  Thiboutot D, Archer DF, Lemay A, Washenik K, Roberts J, Harrison DD. A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment. Fertil Steril. 2001;76(3):461-8.

Sin comentarios todavía

Deje una respuesta

Debe ser conectado como para introducir un comentario